Pharmactive operates in pharmaceutical technology, pharmaceutical chemistry and process development fields in its R&D center housed on an area of 3,200 square meters within modern facilities. 


The company aims to reinforce university-industry collaboration and develop new products using innovative approaches in various therapeutic areas with its specialized R&D staff who hold Bachelor's, Master's and PhD degrees. Pharmactive provides value to the Turkish pharmaceutical industry with its quality products and vision.


On its second anniversary, PharmRD was approved by the Ministry of Science, Industry and Technology as a Pharmaceutical R&D Center. It has applied to the European Union and Turkish authorities to acquire necessary licenses for 156 dosage forms with 101 molecules it has developed in last five years. The center boasts the infrastructure, capacity, know-how and competency to develop all of the dosage forms in line with the EU and other regulated markets.


In line with its QbD based innovative product development approach, PharmRD Center develops generic products that is needed throughout the market in accordance with the regulations of EMEA and ICH. It provides service with its experienced staff, who hold Master's and PhD degrees in the following areas:


• New product formulation development:

• Patent screening

• Product improvement & development

• Project management